Factors affecting the Haemophilia Joint Health Score in children with severe haemophilia

Haemophilia

Volumn 19, Issue 4, 2013, Pages 626-631

  Bladen, M ^a   Main, E ^b   Hubert, N ^a   Koutoumanou, E ^b   Liesner, R ^a   Khair, K ^a  

^a GREAT ORMOND STREET HOSPITAL   (United Kingdom)

^b UNIVERSITY COLLEGE LONDON   (United Kingdom)

Author keywords

Age; Children; HJHS; Inhibitor; Joint score; Prophylaxis

Indexed keywords

ADOLESCENT; ADULT; AGE; ANKLE; ARTICLE; BLEEDING; CHILD; CHILDHOOD DISEASE; CONTROLLED STUDY; DISEASE COURSE; GAIT; HEMOPHILIA A; HEMOPHILIA B; HEMOPHILIA JOINT HEALTH SCORE; HUMAN; IMMUNOLOGICAL TOLERANCE; KNEE; MAJOR CLINICAL STUDY; MALE; PHYSIOTHERAPY; PRESCHOOL CHILD; PRIORITY JOURNAL; PROPHYLAXIS; SCHOOL CHILD; SCORING SYSTEM;

ADOLESCENT; AGE DISTRIBUTION; CHILD; CHILD, PRESCHOOL; HEMOPHILIA A; HEMORRHAGE; HUMANS; JOINTS; LOGISTIC MODELS; MALE; RISK FACTORS;

EID: 84879462891     PISSN: 13518216     EISSN: 13652516     Source Type: Journal    
DOI: 10.1111/hae.12108     Document Type: Article

References (35)

1. Poonnoose PM, Manigandan C, Thomas R et al. Functional Independence score in haemophilia: a new performance-based instrument to measure disability. Haemophilia 2005; 1: 598-602.
2. Van Genderen FR, Fischer K, Heijnen L et al. Pain and functional limitations in patients with severe haemophilia. Haemophilia 2006; 12: 147-53.
3. Roosendaal G, Tekoppele JM, Vanen ME. Articular cartilage is more susceptible to blood-induced cartilage damage at young age than old age. J Rheumatol 2000; 27: 1740-4.
4. Funk M, Schmidt H, Escuriola-Ettingshausen C, Pons S, Dzinaj T, Weimer C et al. Radiological and orthopaedic score in pediatric hemophilic patients with early and late prophylaxis. Ann Hematol 1998; 77: 171-4.
5. Liesner RJ, Khair K, Hann IM. The impact of prophylactic treatment on children with severe haemophilia. Br J Haematol 1996; 92: 973-8.
6. Van Den Berg HM, Fischer K, Van der Bom JG. Comparing outcomes of different treatment regimens for severe haemophilia. Haemophilia 2003; 9: 27-31.
7. Donadel-Claeyssens S on behalf of the European Paediatric network for haemophilia management. Current co-ordinated activities of the PEDNET (European Paediatric Network for Haemophilia Management). Haemophilia 2006; 12: 124-7.
8. Manco-Johnson MJ, Abshire T, Shapiro AD et al. Prophylaxis versus episodic treatment to prevent joint disease in boys with severe haemophilia. N Engl J Med 2007; 357: 535-44.
9. Nilsson IM, Berntorp E, Lovqvist T, Pettersson H. Twenty-five years' experience of prophylactic treatment in severe haemophilia A and B. J Intern Med 1992; 232: 25-32.
10. Fisher K, van der Bom J, Molho P et al. Prophylactic vs on-demand treatment strategies for severe haemophilia: a comparison of costs and long term outcome. Haemophilia 2002; 8: 745-52.
11. Fisher K, Van der Bom J, Mauser-Bunschoten EP et al. The effects of postponing prophylactic treatment on long-term outcome in patients with severe haemophilia. Blood 2002; 99: 2337-41.
12. Kreuz W, Escuriola-Ettingshausen C, Funk M, Schmidt H, Kornhuber B. When should prophylactic treatment in patients with haemophilia A and B start? - The German experience. Haemophilia 1998; 4: 413-7.
13. Richards M, Williams M, Chalmers E et al. Writing group: on behalf of the Paediatric Working Party of the United Kingdom Haemophilia Doctors' Organisation. A United Kingdom Haemophilia Centre Doctors' Organization guideline approved by the British Committee for Standards in Haematology: guideline on the use of prophylactic factor VIII concentrate in children and adults with severe haemophilia A. Br J Haematol 2010; 149: 498-507.
14. Feldman BM, Funk SM, Bergstrom BM et al. Validation of a new pediatric joint scoring system from the international hemophilia prophylaxis study group: validity of the hemophilia joint health score (HJHS). Arthritis Care Res 2011; 68: 2.
15. Gilbert MS. Prophylaxis: musculoskeletal evaluation. Semin Haematol 1993; 30(Suppl. 2): 3-6.
16. Hilliard P, Funk S, Zourikian N et al. Joint Health Score reliability study. Haemophilia 2006; 12: 518-25.
17. Afifi A, Kotlerman J, Ettner A, Cowan M. Methods for improving regression analysis for skewed continuous or counted responses. Annu Rev Public Health 2007; 28: 95-111.
18. Hutchinson MK, Holtman MC. Analysis of count data using poisson regression. Res Nurs Health 2005; 28: 408-18.
19. Vuong Q. Likelihood ratio tests for model selection and non-nested hypotheses. Econometrica 1989; 57: 307-33.
20. McElduff F, Cortina-Borja M, Chan S, Wade A. When t-tests and Wilcoxon-Mann-Whitney tests won't do. Adv Physiol Educ 2010; 34: 128-33.
21. Saulyte TS, Inderslev J, Rageliene L. Utility of the Haemophilia Joint health score in study of episodically treated boys with severe haemophilia A and B in Lithuania. Haemophilia 2010; 16: 479-86.
22. Hoots WK, Nugent DJ. Evidence for the benefits of prophylaxis in the management of haemophilia A. Thromb Haemost 2006; 96: 433-40.
23. Pannicker J, Warrier I, Thomas R, Lusher JM. The overall effectiveness of prophylaxis in severe haemophilia. Haemophilia 2003; 9: 272-8.
24. Aledort LM, Haschmeyer RH, Pattersson H. A longitudinal study of orthopaedic outcomes for severe factor VIII deficient haemophiliacs. Haemophilia 1994; 236: 391-9.
25. Carcao M, Chambost H, Ljung R. Devising a best practice approach to prophylaxis in boys with severe haemophilia: evaluation of current treatment strategies. Haemophilia 2010; 16: 4-9.
26. Berntorp E, Astermark J, Bjorkman S et al. Consensus perspectives on prophylactic therapy in haemophilia: summary statement. Haemophilia 2003; 9(Suppl. 1): 1-4.
27. Ljung R, Meeting report. Second Workshop of the European Paediatric Network for haemophilia Management, 17-19 September 1988 in Vitznau/Switzerland. Haemophilia 1999; 5: 286-91.
28. Van Den Berg HM, Dunn A, Fisher K, Blanchette VS. Prevention and treatment of musculoskeletal disease in the haemophilia population: role of prophylaxis and synovectomy. Haemophilia 2006; 12(Suppl. 3): 159-68.
29. Engelbert RHH, Plantinga M, Van der Net J et al. Aerobic capacity in children with haemophilia. J Pediatr 2008; 152: 833-8.
30. Feldman BM, Funk SM, Bergstrom BM et al. Validation of a new pediatric joint scoring system from the international hemophilia prophylaxis study group: validity of the hemophilia joint health score. Arthritis Care Res 2011; 63: 223-30.
31. Chen L, Sun J, Wu R. Joint Health status in Chinese haemophilia children: a pilot study using the haemophilia joint health assessment scale (HJHS). (Abstracts of the XXV111th International Congress of the World Federation of Haemophilia). Haemophilia 2008; 14(Suppl. 2): 79.
32. Hay RM, Dimichelle DM. The Principal results of the International Immune Tolerance Study: a randomised dose comparison. Haemophilia 2012; 119: 1335-44.
33. Stephenson D, Tait RC, Brodie N et al. Changing patterns of bleeding in patients with severe haemophilia A. Haemophilia 2009; 15: 1210-4.
34. Tussell JM, Aznar JA, Querol F, Quintana M, Moreno M, Gorina E and the Orthopaedic study group. Results of an orthopaedic survey in young patients with severe haemophilia in Spain. Haemophilia 2002; 8(Suppl. 2): 38-42.
35. Groen W, Van der Net J, Bos K et al. Joint Health and functional ability in children with haemophilia who receive intensive replacement therapy. Haemophilia 2011; 17: 783-90.